Simbec Orion

Silver Sponsor

There are many unique challenges that can hinder complex, hospital-based, clinical studies, such as those for rare disease and oncology trials. Simbec-Orion is a responsive and agile full-service CRO, with wide therapeutic experience and specialist expertise in clinical pharmacology, oncology, and rare disease.
Maintaining investor confidence, and therefore securing additional funding for clinical development, makes meeting your milestones a top priority. With a business model that is perfectly structured to provide clinical development solutions for small to mid-size pharmaceutical clients, our agile set-up ensures we can flex resources to shorten timelines and mitigate risk, providing you with the data you need to support your decisions at every stage of your clinical development program.
From maximising site selection, to forming close links with patient advocacy groups, and enrolling patients, we overcome hurdles and help you get medicines to market. Supported by industry-leading technology platforms, you can choose from a portfolio of fully integrated or stand-alone service solutions for your specific clinical development needs. We can also enhance your protocol development and advise on study design approach with our scientific affairs and medical teams.
Partnering with Simbec-Orion will help you achieve your clinical and commercial objectives, because your goal is the same as ours; to improve patients’ lives. Learn more at


World Orphan Drug Congress


The World Orphan Drug Congress provides you with a one stop progressive scientific and strategic solution to the orphan drugs industry.




World Orphan Drug Congress

Rare Disease Day



Contact us

To sponsor or exhibit:
Michael Hodge

To speak:
Wing-Yun Cheung

Nadia Konneh